Home > ELISA KIT > General Elisa Kit > General ADMA/ Asymmetric dimethylarginine ELISA Kit

General ADMA/ Asymmetric dimethylarginine ELISA Kit

General ADMA/ Asymmetric dimethylarginine ELISA Kit
Total

Product Summary

NO.:E0003Ge

Assay range:15.6-1000ng/mL

Sensitivity:5.4ng/mL

Method:Competitive

    Number:

Details

Intended use
This immunoassay kit allows for the in vitro quantitative determination of General ADMA concentrations in serum, Plasma, tissue homogenates and Cell culture supernates and Other biological fluids.
Test principle
The ELISA is based on the competitive binding enzyme immunoassay technique. The microtiter plate provided in this kit has been pre-coated with an antibody specific to General ADMA, During the reaction, General ADMA in the sample or standard competes with a fixed amount of biotin-labeled General ADMA for sites on a pre-coated Monoclonal antibody specific to General ADMA. Excess conjugate and unbound sample or standard are washed from the plate. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. Then a TMB substrate solution is added to each well. The enzyme-substrate reaction is terminated by the addition of a sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The concentration of General ADMA in the samples is then determined by comparing the O.D. of the samples to the standard curve.

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Asymmetric dimethylarginine and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample

1:2

1:4

1:8

1:16

serum(n=5)

103-113%

104-113%

109-119%

93-102%

EDTA plasma(n=5)

104-114%

90-100%

83-92%

99-109%

heparin plasma(n=5)

93-103%

 

89-97%

96-104%

102-112%

 Sequence:C8H18N4O2

 

Partial purchase records (2)

UsernameQuantitybought time
Qu***12024-06-22
Iv***12021-04-04
Total 2 records, divided into1 pages. First Prev Next Last

Leave a message

* To protect against spam, please pass the CAPTCHA test below.

Newsletter

Sign up
0 0